Skip to content

NYSE · CIK 0000885590

BHC Bausch Health Companies Inc.

Insider trading from SEC Form 4. Last filing 10 d ago. Close $6.04 on Oct 9, 2026, +36% from the 52-week low and -24% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company

Price and insider trades, last year

BHCOct 9, 2026 · close 6.04

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Bausch Health Companies Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
56ModerateJohn Paulson
director
buy
$21M
3,564,059 shares
+12%+38% from low-39% from high
51ModerateJohn Paulson
director
buy
$15M
2,788,608 shares
+11%+18% from low-48% from high
0WeakSeana Carson
EVP, General Counsel
sell
$3,674
440 shares
-0%-

Transactions

The last 37 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026Sandra Leung
director
AGrant or award
Common Shares, No Par Value
+5,789$5.83$34k102,85910 d ago
Sep 30, 2026Amy B Wechsler
director
AGrant or award
Common Shares, No Par Value
+1,179$5.83$6,874316,15810 d ago
Sep 30, 2026John Paulson
director
AGrant or award
Common Shares, No Par Value
+10,720$5.83$62k440,96210 d ago
Jun 13, 2025John Paulson
director
POpen-market purchase
Common Stock, no par valueindirect: By Managed Funds
+3,564,059$5.94$21M32,791,702Jun 17, 2025
Jun 10, 2025John Paulson
director
POpen-market purchase
Common Stock, no par valueindirect: By Managed Funds
+754,134$5.05$3.8M27,193,169Jun 12, 2025
Jun 11, 2025John Paulson
director
POpen-market purchase
Common Stock, no par valueindirect: By Managed Funds
+1,029,098$5.24$5.4M28,222,267Jun 12, 2025
Jun 12, 2025John Paulson
director
POpen-market purchase
Common Stock, no par valueindirect: By Managed Funds
+1,005,376$5.47$5.5M29,227,643Jun 12, 2025
May 16, 2025Amy B Wechsler
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0263,355May 20, 2025
May 16, 2025Robert N Power
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0254,723May 20, 2025
May 16, 2025John Paulson
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0332,055May 20, 2025
May 16, 2025Richard Mulligan
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0155,616May 20, 2025
May 16, 2025Steven D Miller
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0229,224May 20, 2025
May 16, 2025Frank D. Lee
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$089,707May 20, 2025
May 16, 2025Sarah B Kavanagh
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0236,359May 20, 2025
May 16, 2025Brett Icahn
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$0216,246May 20, 2025
May 16, 2025Christian A Garcia
director
AGrant or award
Common Shares, No Par Value
+54,347$0.00$089,707May 20, 2025
Mar 31, 2025Amy B Wechsler
director
AGrant or award
Common Shares, No Par Value
+1,062$6.47$6,871209,008Apr 1, 2025
Mar 31, 2025John Paulson
director
AGrant or award
Common Shares, No Par Value
+9,659$6.47$62k277,708Apr 1, 2025
Mar 31, 2025Brett Icahn
director
AGrant or award
Common Shares, No Par Value
+5,119$6.47$33k161,899Apr 1, 2025
Feb 28, 2025Thomas Appio
Chief Executive Officer
FTax withholding
Common Shares, No Par Value
-24,838$7.44$185k1,965,260Mar 3, 2025
Feb 28, 2025John S Barresi
SVP, Controller & CAO
FTax withholding
Common Shares, No Par Value
-2,865$7.44$21k197,364Mar 3, 2025
Feb 28, 2025Seana Carson
EVP, General Counsel
FTax withholding
Common Shares, No Par Value
-5,994$7.44$45k607,590Mar 3, 2025
Feb 28, 2025Thomas Appio
Chief Executive Officer
FTax withholding
Common Shares, No Par Value
-85,100$7.44$633k1,880,160Mar 3, 2025
Feb 28, 2025John S Barresi
SVP, Controller & CAO
FTax withholding
Common Shares, No Par Value
-5,096$7.44$38k192,268Mar 3, 2025
Feb 28, 2025Seana Carson
EVP, General Counsel
FTax withholding
Common Shares, No Par Value
-16,973$7.44$126k590,617Mar 3, 2025
Feb 28, 2025Thomas Appio
Chief Executive Officer
FTax withholding
Common Shares, No Par Value
-96,911$7.44$721k1,783,249Mar 3, 2025
Feb 28, 2025Seana Carson
EVP, General Counsel
FTax withholding
Common Shares, No Par Value
-26,325$7.44$196k564,292Mar 3, 2025
Feb 26, 2025Thomas Appio
Chief Executive Officer
AGrant or award
Common Shares, No Par Value
+635,425$0.00$01,990,098Feb 28, 2025
Feb 26, 2025Aimee J. Lenar
EVP, US Pharma
AGrant or award
Common Shares, No Par Value
+108,311$0.00$0252,663Feb 28, 2025
Feb 26, 2025Seana Carson
EVP, General Counsel
AGrant or award
Common Shares, No Par Value
+180,518$0.00$0613,584Feb 28, 2025
Feb 26, 2025Jean-Jacques Charhon
EVP, CFO
AGrant or award
Common Shares, No Par Value
+216,622$0.00$0515,460Feb 28, 2025
Feb 26, 2025John S Barresi
SVP, Controller & CAO
AGrant or award
Common Shares, No Par Value
+49,823$0.00$0200,229Feb 28, 2025
Dec 31, 2024Brett Icahn
director
AGrant or award
Common Shares, No Par Value
+4,109$8.06$33k156,780Jan 2, 2025
Dec 31, 2024John Paulson
director
AGrant or award
Common Shares, No Par Value
+7,754$8.06$62k268,049Jan 2, 2025
Dec 31, 2024Amy B Wechsler
director
AGrant or award
Common Shares, No Par Value
+852$8.06$6,867207,946Jan 2, 2025
Nov 29, 2024Seana Carson
EVP, General Counsel
FTax withholding
Common Shares, No Par Value10b5-1
-1,692$8.37$14k433,506Dec 3, 2024
Dec 2, 2024Seana Carson
EVP, General Counsel
SOpen-market sale
Common Shares, No Par Value10b5-1
-440$8.35$3,674433,066Dec 3, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BHC insider trading: Bausch Health Companies Inc. | InsiderTell